Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis
Author:
Affiliation:
1. Department of Medical Sciences, Dermatologic Clinic University of Turin Turin Italy
Publisher
Wiley
Subject
Dermatology,Molecular Biology,Biochemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14822
Reference7 articles.
1. Update on Epidemiology, Diagnosis, and Disease Course of Atopic Dermatitis
2. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
3. Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice
4. Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period
5. Disease and Treatment Characteristics in Geriatric Psoriasis: A Patient Survey Comparing Age Groups
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years;Journal of the European Academy of Dermatology and Venereology;2023-12-26
2. Psoriasis in Norway: a prescription-based registry study of psoriasis-associated comorbidities;European Journal of Dermatology;2023-12
3. Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study;Journal of Clinical Medicine;2023-11-21
4. Effectiveness and safety of anti‐IL‐23 and anti‐IL‐17 biological therapies for psoriasis in elderly patients: Real‐world experience from two Italian hospitals;Journal of the European Academy of Dermatology and Venereology;2023-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3